DrBicuspid

Aspirin could prevent hearing loss from chemo

Researchers in the U.K. are launching a phase II trial to see if high doses of aspirin can help prevent permanent hearing loss, a common side effect among cancer patients given the chemotherapy drug ...
DrBicuspid

Aspirin reduces risk of Barrett's esophagus

Aspirin use appears to reduce the risk of Barrett's esophagus, the largest known risk factor for esophageal cancer, according to a new study in Clinical Gastroenterology and Hepatology, (July 2012, ...
The Fayetteville Observer

Aspire Biopharma Holdings, Inc., Announces Last Patient Dosed in Phase 1 Clinical Trial of its Oral Transmucosal Fast-Acting High-Dose Aspirin Formulation

ESTERO, FL AND NEW YORK, NY / ACCESS Newswire / June 24, 2025 / Aspire Biopharma Holdings, Inc. (Nasdaq:ASBP) (“Aspire” or the “Company”), developer of a multi-faceted patent-pending drug delivery ...
The Journal News

Aspire Biopharma Announces Breakthrough Final Results from Clinical Trial of Investigational New Sublingual Aspirin Product for Treatment of Suspected Acute Myocardial ...

ESTERO, FLORIDA / ACCESS Newswire / September 3, 2025 / Aspire Biopharma Holdings, Inc. (NASDAQ:ASBP) (“Aspire” or the “Company”), developer of a multi-faceted patent-pending drug delivery technology, ...
TCTMD

Stopping DOACs After Successful AF Ablation Feasible in Low-risk Patients: OCEAN

OCEAN, said Albert, provides important risk-benefit data that doctors can now use in discussions with their patients. For ...